These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 35129214)

  • 1. Antiepileptic drugs for the primary and secondary prevention of seizures after stroke.
    Chang RS; Leung WC; Vassallo M; Sykes L; Battersby Wood E; Kwan J
    Cochrane Database Syst Rev; 2022 Feb; 2(2):CD005398. PubMed ID: 35129214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiepileptic drugs for seizure control in people with neurocysticercosis.
    Walton D; Castell H; Collie C; Wood GK; Sharma M; Singh T; Michael BD
    Cochrane Database Syst Rev; 2021 Nov; 11(11):CD009027. PubMed ID: 34723391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic drug management for febrile seizures in children.
    Offringa M; Newton R; Nevitt SJ; Vraka K
    Cochrane Database Syst Rev; 2021 Jun; 6(6):CD003031. PubMed ID: 34131913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immediate antiepileptic drug treatment, versus placebo, deferred, or no treatment for first unprovoked seizure.
    Leone MA; Giussani G; Nevitt SJ; Marson AG; Beghi E
    Cochrane Database Syst Rev; 2021 May; 5(5):CD007144. PubMed ID: 33942281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregabalin add-on for drug-resistant focal epilepsy.
    Panebianco M; Bresnahan R; Marson AG
    Cochrane Database Syst Rev; 2022 Mar; 3(3):CD005612. PubMed ID: 35349176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brivaracetam add-on therapy for drug-resistant epilepsy.
    Bresnahan R; Panebianco M; Marson AG
    Cochrane Database Syst Rev; 2022 Mar; 3(3):CD011501. PubMed ID: 35285519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatments for seizures in catamenial (menstrual-related) epilepsy.
    Maguire MJ; Nevitt SJ
    Cochrane Database Syst Rev; 2021 Sep; 9(9):CD013225. PubMed ID: 34528245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiepileptic drugs for seizure control in people with neurocysticercosis.
    Frackowiak M; Sharma M; Singh T; Mathew A; Michael BD
    Cochrane Database Syst Rev; 2019 Oct; 10(10):CD009027. PubMed ID: 31608991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lamotrigine add-on therapy for drug-resistant generalised tonic-clonic seizures.
    Bresnahan R; Panebianco M; Marson AG
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD007783. PubMed ID: 32609387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gabapentin add-on treatment for drug-resistant focal epilepsy.
    Panebianco M; Al-Bachari S; Hutton JL; Marson AG
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD001415. PubMed ID: 33434292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregabalin add-on for drug-resistant focal epilepsy.
    Panebianco M; Bresnahan R; Hemming K; Marson AG
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD005612. PubMed ID: 31287157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulant and non-stimulant drug therapy for people with attention deficit hyperactivity disorder and epilepsy.
    Eaton C; Yong K; Walter V; Mbizvo GK; Rhodes S; Chin RF
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD013136. PubMed ID: 35844168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carisbamate add-on therapy for drug-resistant focal epilepsy.
    Lu C; Zheng J; Cao Y; Bresnahan R; Martin-McGill KJ
    Cochrane Database Syst Rev; 2021 Dec; 12(12):CD012121. PubMed ID: 34870321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lamotrigine add-on therapy for drug-resistant focal epilepsy.
    Panebianco M; Bresnahan R; Ramaratnam S; Marson AG
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD001909. PubMed ID: 32196639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxcarbazepine add-on for drug-resistant focal epilepsy.
    Bresnahan R; Atim-Oluk M; Marson AG
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD012433. PubMed ID: 32129501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid versus slow withdrawal of antiepileptic drugs.
    Ayuga Loro F; Gisbert Tijeras E; Brigo F
    Cochrane Database Syst Rev; 2022 Jan; 1(1):CD005003. PubMed ID: 35005782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lamotrigine add-on therapy for drug-resistant focal epilepsy.
    Panebianco M; Bresnahan R; Marson AG
    Cochrane Database Syst Rev; 2023 Dec; 12(12):CD001909. PubMed ID: 38078494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulatory interventions for focal epilepsy.
    Panebianco M; Walker L; Marson AG
    Cochrane Database Syst Rev; 2023 Oct; 10(10):CD009945. PubMed ID: 37842826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brivaracetam add-on therapy for drug-resistant epilepsy.
    Bresnahan R; Panebianco M; Marson AG
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD011501. PubMed ID: 30920649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.